4D 725
Alternative Names: 4D-725Latest Information Update: 08 Jan 2024
At a glance
- Originator 4D Molecular Therapeutics
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Alpha 1-antitrypsin deficiency